Jagsonpal Pharmaceuticals Ltd.
| BSE: 507789 | Sector: Health care |
| NSE: JAGSNPHARM | ISIN Code: INE048B01027 |
| BSE 00:00 | 27 Jan | 350.35 |
-6.00 (-1.68%) |
OPEN
355.35 |
HIGH
357.35 |
LOW
345.00 |
| NSE 00:00 | 27 Jan | 349.95 |
-7.25 (-2.03%) |
OPEN
358.90 |
HIGH
361.30 |
LOW
345.05 |
| OPEN | 355.35 |
| PREVIOUS CLOSE | 356.35 |
| VOLUME | 1073 |
| 52-Week high | 420.20 |
| 52-Week low | 156.75 |
| P/E | 44.52 |
| Mkt Cap.(Rs cr) | 918 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) - Net Profit
Net Profit
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
| Cipla | 1047.05 | 12.65 | 1.22 | 2957.93 |
| Divi's Lab. | 3385.55 | 49.05 | 1.47 | 2948.54 |
| Glenmark Pharma. | 381.40 | -17.60 | -4.41 | 1997.79 |
| Glaxosmi. Pharma | 1261.60 | -1.35 | -0.11 | 1690.53 |
| Dr Reddy's Labs | 4318.30 | 113.75 | 2.71 | 1623.20 |
| Alkem Lab | 2997.60 | -16.20 | -0.54 | 1541.25 |
| Aurobindo Pharma | 416.25 | -1.60 | -0.38 | 1454.71 |
| Gland Pharma | 1357.10 | 15.55 | 1.16 | 1212.16 |
| Torrent Pharma. | 1537.80 | -19.70 | -1.26 | 991.45 |
| Sanofi India | 5580.95 | -45.70 | -0.81 | 944.40 |
| Ipca Labs. | 850.60 | -13.40 | -1.55 | 870.94 |
| Zydus Lifesci. | 430.25 | 4.15 | 0.97 | 857.90 |
| Abbott India | 21219.85 | -60.15 | -0.28 | 798.70 |
| Laurus Labs | 341.85 | -0.15 | -0.04 | 750.09 |
| Ajanta Pharma | 1181.85 | -11.55 | -0.97 | 719.86 |
| Apollo Hospitals | 4243.30 | 18.20 | 0.43 | 665.20 |
| Pfizer | 4000.70 | -13.75 | -0.34 | 612.56 |
| Suven Pharma | 491.30 | 2.30 | 0.47 | 558.10 |
| Alembic Pharma | 538.10 | -7.85 | -1.44 | 543.55 |
| Glenmark Life | 390.45 | 0.50 | 0.13 | 418.72 |
Quick Links for Jagsonpal Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
